Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MME | P08473 | 2/20 | 0.30 |
| ▸ | ACE | P12821 | 2/20 | 0.30 |
| ▸ | CPA1 | P15085 | 2/20 | 0.30 |
| ▸ | ACE2 | Q9BYF1 | 2/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13624877 | 0.97 | MME (0.31) | MMEACECPA1ACE2 | |
| SCHEMBL18609114 | 0.80 | TSHR (0.40) | — | |
| SCHEMBL18584314 | 0.80 | TSHR (0.40) | — | |
| SCHEMBL24831222 | 0.77 | — | — | |
| SCHEMBL10314801 | 0.77 | MME (0.30) | MMEACECPA1ACE2 | |
| SCHEMBL22875963 | 0.77 | — | — | |
| SCHEMBL13853470 | 0.74 | METAP1 (0.33) | — | |
| SCHEMBL23207 | 0.74 | — | — | |
| SCHEMBL598937 | 0.73 | TSHR (0.40) | — | |
| SCHEMBL19290491 | 0.73 | TSHR (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080096198-A1 | Primer Having Promoter Region Added Thereto | NIHON UNIVERSITY (JP) | 2008-04-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080096198-A1 | Primer Having Promoter Region Added Thereto | RNGTT, LEO1, RIOX2 | MME 3487/4885ACE 3374/4885CPA1 754/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.